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For the past 3 decades there has been a heated contro-
versy in the world of coronary artery bypass graft 
(CABG) surgery. This has concerned whether to 
perform CABG with (on pump) or without (off pump) 
cardiopulmonary bypass. Each technique has advan-
tages and shortcomings. For example on pump has often 
been associated with a small risk of stroke, whereas off 
pump reduces aortic manipulation [1]. Both approaches 
have been implicated in a systemic inflammatory 
response [1]. Despite >60 meta-analyses investigating 
this topic no conclusive answer has been reached and 
the debate continues [1]. 
Two of the problems encountered when seeking 
evidence are the sparsity of large randomised controlled 
trials (RCTs) and a focus on short-term clinical out-
comes. A possible resolution to the latter was the long 
awaited publication of the five-year outcomes of two of 
the largest RCTs to date, ROOBY (Randomized on/off 
bypass) [2] and CORONARY (CABG off or on pump 
revascularization) [3] trials. This enabled a fresh meta-
analysis investigating long-term clinical outcomes 
(mortality, myocardial infarction, stroke, angina and the 
need for revascularisation) incorporating 6 RCTs, and, 
most importantly, including ROOBY and CORONARY. 
The results showed a small but significant benefit of on 
pump in terms of mortality with all other comparisons 
showing no differences [4]. This raises a new question 
what is the reason/mechanism underlying on pump’s 
seemingly superior long-term survival rate? 
A criticism that is often levelled at off pump CABG is 
the under achievement of complete revascularisation. 
This might arise from the greater technical challenge of 
performing distal anastomoses on the beating heart, 
although surgeon experience is thought to be a factor 
[1]. In the CORONARY trial significantly fewer grafts 
were placed in the off pump group, and the rate of 
incomplete revascularisation was higher in the off pump 
group, though the p value was borderline significant 
(p=0.05) [5]. A similar pattern was observed in ROOBY 
where less grafts were placed in the off pump group and 
the number of grafts placed that was lower than planned 
was significantly higher in the off pump group [6]. The 
consequences of this might be a significant re-
emergence of angina, higher occurrence of myocardial 
infarction and a greater need for revascularisation in the 
off pump group. Only 3 of the 6 RCTs in the long-term 
comparison meta-analysis reported the incidence  of  an- 
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gina at >4 years including CORONARY but not 
ROOBY [4]. Yet the result was insignificant [4]. Both 
CORONARY and ROOBY reported the incidence of 
repeat revascularisation (plus three other studies) yield-
ing an insignificant odds ratio of 1.15 (95% confidence 
interval [CI] 0.95 to 1.40) overall. The same five RCTs 
reported the incidence of myocardial infarction and 
again the odds ratio (1.06 [95% CI 0.91 to 1.25]) for the 
comparison was insignificant [4]. It is noteworthy that 
in the 5-year follow ups published about the 
CORONARY and ROOBY RCTs death from cardio-
vascular causes was measured. No significant difference 
was found for off pump compared to on pump [2-3]. 
If greater susceptibility to cardiovascular events 
including stroke is not the underlying mechanism what 
is the cause of the lower longevity in the off pump 
group? Another parameter that was measured in 
CORONARY that could be a cause of premature death 
was new renal failure requiring dialysis. However at 
five years there was no difference in the rate in the off 
pump group compared to on the pump group [3]. It is 
well known that as time passes patients undergoing 
CABG are becoming older and have a higher number of 
comorbidities. There is also a body of evidence to 
suggest that off pump is favoured in high risk patients 
[1]. Equally well known is that advancing age and 
lifestyle choices are risk factors for the development of 
dementia. Could there be a difference in the suscep-
tibility of the off and on pump groups to the onset and 
progression of dementia? An early warning sign of the 
onset of dementia is cognitive decline. This was 
measured by Van Dijk et al in their five year follow-up 
to an RCT comparing off versus on pump. A reduction 
in cognitive performance occurred in both groups; 
however, it only reached significance in the on pump 
group [7]. Another dead end lies in comparing health 
related quality of life, which was similar for surviving 
patients at follow-up for 3 RCTs [5, 7, 8]. 
In conclusion a recent meta-analysis found a small but 
significant long-term survival advantage for patients 
undergoing on pump CABG compared to those 
undergoing off pump CABG. Several avenues including 
cardiovascular causes, renal causes, dementia causes 
and health related quality of life causes have been 
explored in the search for an underlying mechanism to 
explain on pump’s long-term superiority with respect to 
mortality. Unfortunately, no satisfactory explanation 
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has been reached and the question as to why on pump is 
better in terms of mortality in the long-term requires 
further investigation. 
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